# Johnson & Johnson (JNJ) — Q3-2010 Earnings Results

**Report date:** 2010-10-19 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2010

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Down 0.89%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.23 | N/A | +7.05% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a positive outlook on product performance. However, they did not offer specific guidance for the upcoming quarters.

**Key quotes:**

> Management highlighted strong performance in key product lines.

> They expressed confidence in ongoing operational improvements.

> No specific guidance was provided for future quarters.

### Guidance Changes

No forward guidance was provided in this earnings report.

### What It Means

Johnson & Johnson's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 0.89%. This could be due to the lack of revenue data and absence of future guidance, leaving investors uncertain about the company's direction.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2010_